St Pharm Co., Ltd. is engaged in manufacturing APIs and intermediates. The company operates in four business segments : New Drug CMO is engaged in manufacturing new drugs for Hepatitis C, Antibiotics, Anti-cancer, diabetes, among others; Generic APIs is engaged in manufacturing and distribution of anti- cancer medicines, anti-HIV/AIDS, anti-tuberculosis, COPD, epilepsy, MRI contrast agent, anti-coagulant, anti-hyperlipidemia, asthma, cough suppresant, Hepatitis B, Anti-fungal, etc. ; Fine chemicals is engaged in manufacturing advanced materials for batteries, electronic materials and polymer catalysts; and BIO is engaged in developing oligonucleotide therapeutics. St Pharm Co.,Ltd. was established in 1983 formerly known as Samchully Pharmaceutical. The company is based in Seoul, South Korea.
Headquarters
231, Hyeopryeok-Ro, Siheung-Si, Gyeonggi-Do
Siheung; Gyeonggi;
Contact Details: Purchase the St Pharm Co., Ltd. (Siheung) report to view the information.
Website: http://www.stpharm.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service